Beta-blocker use linked to improved ovarian cancer survival. More trials needed to understand results.
Women with epithelial ovarian cancer who happened to be taking nonselective beta-blockers for hypertension survived longer than those who were not taking the drugs, according to a large multicenter retrospective … Continue reading
Women born with mutations in the genes BRCA1 or BRCA2 have an increased risk of developing breast and ovarian cancer. But not all mutations within these genes raise the risk … Continue reading